Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MUC1 peptide epitopes associated with five different H-2 class I molecules

V Apostolopoulos1, J S Haurum, I F McKenzie

  • 1Austin Research Institute, Victoria, Australia. Vasso_Apostolopoulos@muwayf.unimelb.edu.au

European Journal of Immunology
|November 22, 1997
PubMed
Summary

Researchers identified specific T cell epitopes within the MUC1 cancer antigen. These findings are crucial for developing targeted immunotherapies against breast cancer by understanding how cytotoxic T cells recognize MUC1 peptides presented by major histocompatibility complex molecules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice.

Transplantation·2000
Same author

Human monocytes bind to ligands on porcine endothelium containing the gal alpha (1,3)-Gal antigen.

Transplantation proceedings·2000
Same author

Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice.

Vaccine·2000
Same author

Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway.

European journal of immunology·2000
Same author

A role for IL-5 in the induction of cytotoxic T lymphocytes in vivo.

European journal of immunology·2000
Same author

The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan.

Vaccine·2000

Area of Science:

  • Immunology
  • Cancer Research
  • Molecular Biology

Background:

  • The human mucin 1 (MUC1) variable number of tandem repeats (VNTR) region is overexpressed in breast cancer, making it a potential target for immunotherapy.
  • Murine CD8+ cytotoxic T cells (CTLs) recognizing MUC1 VNTR peptides have been previously induced.

Purpose of the Study:

  • To identify and characterize distinct T cell epitopes presented by different major histocompatibility complex (MHC) class I molecules within the MUC1 VNTR.
  • To understand the binding characteristics and T cell recognition of these MUC1-derived epitopes.

Main Methods:

  • Cytotoxic T cell (CTL) assays using peptide-pulsed cells and MHC class I-transfected cells.
  • Peptide binding assays.
  • T cell proliferation studies.

Related Experiment Videos

  • Analysis of epitope sequences and binding motifs.

    • Main Results:

    • Nine potential T cell epitopes were defined within the MUC1 VNTR.
    • Epitopes presented by MHC class I molecules Kb, Dd, Ld, and Kk shared a common motif (PDTRPAP), while Db-presented epitopes contained APGSTAP.
    • Most identified epitopes exhibited low binding affinity to their respective MHC class I molecules.
    • T cell proliferation correlated with MHC class I-presented epitopes.
    • Modifying peptides with conventional anchor residues altered binding affinity and CTL recognition.

    Conclusions:

    • Specific MUC1 VNTR epitopes are presented by various MHC class I molecules, offering targets for cancer immunotherapy.
    • The binding and recognition of these epitopes are complex and do not always follow established motif rules.
    • Understanding these epitope-MHC interactions is key for designing effective MUC1-based cancer vaccines and therapies.